Gilead Sciences sets aside $200 million to resolve HIV drug probe
Gilead Sciences set aside $200 million for a potential settlement with federal prosecutors to resolve an investigation into ...
Our progress in ending the HIV/AIDS epidemic shows the importance of federal support
We can now prevent HIV transmissions and deaths — progress impossible without investments from the U.S. government ...
FiercePharma1d
How studying innovative HIV medicines in the “real world” helps HCPs and patients make the best decisions for treatment and prevention
| Dr. Buzón discusses bridging science and reality, highlighting the vital role of real-world evidence in advancing HIV care ...
Rolling Out5d
HIV breakthrough faces critical funding cuts
A revolutionary advancement in HIV prevention technology stands at a critical crossroads as recent policy decisions threaten ...
MadameNoire6d
HIV Myth-Busters: Debunking The Biggest Misconceptions In Black Communities
MadameNoire breaks down three common myths about HIV that persist today. Together, let's uncover the truth behind the stigma.
FiercePharma3h
Gilead sets aside $200M for potential settlement over HIV drug speaker program
Weeks after settling a five-year patent dispute with the U.S. | Gilead set aside approximately $200 million for a potential ...
News241h
The Global Fund will roll out the twice-yearly anti-HIV jab – with or without Pepfar
The Global Fund to Fight AIDS, Tuberculosis and Malaria says it will fund the rollout of the twice-yearly anti-HIV jab, ...
devdiscourse16h
Funding Freeze: LGBTQ+ and HIV Advocacy at Risk as USAID Withdraws Support
USAID's withdrawal of funding significantly impacts LGBTQ+ advocacy and HIV services in the Philippines. Organizations like ...
Bangor officials discuss increase in HIV cases in Penobscot County
BANGOR, Maine (WABI) - The Maine CDC has announced there are now 21 confirmed cases of HIV in Penobscot County. During a ...
Science Daily2d
HIV and AIDS News
Understanding how ... A Chain Reaction: HIV Vaccines Can Lead to Antibodies Against Antibodies Jan. 17, 2025 — Many vaccines work by introducing a protein to the body that resembles part of a virus.
Aidsmap1h
aidsmap returns with reporting from the Conference on Retroviruses and Opportunistic Infections (CROI)
News reporting will resume with coverage of the Conference on Retroviruses and Opportunistic Infections (CROI), being held in San Francisco from 9 to 12 March. Our reporting team from CROI are Keith ...